메뉴 건너뛰기




Volumn 10, Issue 12, 2014, Pages 708-722

Neuroimaging in Parkinson disease: From research setting to clinical practice

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE TRANSPORTER; FLUORODEOXYGLUCOSE F 18; GLUCOSE; IODOBENZAMIDE I 123; IOFLUPANE I 123; LEVODOPA; PLACEBO; PRAMIPEXOLE; RADIOPHARMACEUTICAL AGENT; ROPINIROLE; UNCLASSIFIED DRUG;

EID: 84927173773     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2014.205     Document Type: Review
Times cited : (200)

References (182)
  • 1
    • 84055193505 scopus 로고    scopus 로고
    • The economic cost of brain disorders in Europe
    • Olesen, J. et al. The economic cost of brain disorders in Europe. Eur. J. Neurol. 19, 155-162 (2012).
    • (2012) Eur. J. Neurol , vol.19 , pp. 155-162
    • Olesen, J.1
  • 2
    • 80555135824 scopus 로고    scopus 로고
    • The aging brain and neurodegenerative diseases
    • Duncan, G. W. The aging brain and neurodegenerative diseases. Clin. Geriatr. Med. 27, 629-644 (2011).
    • (2011) Clin. Geriatr. Med , vol.27 , pp. 629-644
    • Duncan, G.W.1
  • 3
    • 2542596183 scopus 로고    scopus 로고
    • Parkinson's disease
    • Samii, A., Nutt, J. G. & Ransom, B. R. Parkinson's disease. Lancet 363, 1783-1793 (2004).
    • (2004) Lancet , vol.363 , pp. 1783-1793
    • Samii, A.1    Nutt, J.G.2    Ransom, B.R.3
  • 4
    • 0025954066 scopus 로고
    • Ageing and Parkinson's disease: Substantia nigra regional selectivity
    • Fearnley, J. M. & Lees, A. J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283-2301 (1991).
    • (1991) Brain , vol.114 , pp. 2283-2301
    • Fearnley, J.M.1    Lees, A.J.2
  • 5
    • 77955844658 scopus 로고    scopus 로고
    • Staging of serotonergic dysfunction in Parkinson's disease: An in vivo 11C-DASB PET study
    • Politis, M. et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol. Dis. 40, 216-221 (2010).
    • (2010) Neurobiol. Dis , vol.40 , pp. 216-221
    • Politis, M.1
  • 6
    • 84912079277 scopus 로고    scopus 로고
    • Serotonin in Parkinson's disease
    • Politis, M. & Niccolini, F. Serotonin in Parkinson's disease. Behav. Brain. Res. http://dx.doi.org/10.1016/j.bbr.2014.07.037.
    • Behav. Brain. Res
    • Politis, M.1    Niccolini, F.2
  • 7
    • 14744290753 scopus 로고    scopus 로고
    • Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
    • Hallett, P. J. et al. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Neuropharmacology 48, 503-516 (2005).
    • (2005) Neuropharmacology , vol.48 , pp. 503-516
    • Hallett, P.J.1
  • 8
    • 0030727688 scopus 로고    scopus 로고
    • Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias
    • Piccini, P., Weeks, R. A. & Brooks, D. J. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias. Ann. Neurol. 42, 720-726 (1997).
    • (1997) Ann. Neurol , vol.42 , pp. 720-726
    • Piccini, P.1    Weeks, R.A.2    Brooks, D.J.3
  • 9
    • 20944435840 scopus 로고    scopus 로고
    • High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients
    • Pisani, A. et al. High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. Ann. Neurol. 57, 777-779 (2005).
    • (2005) Ann. Neurol , vol.57 , pp. 777-779
    • Pisani, A.1
  • 10
    • 0033010467 scopus 로고    scopus 로고
    • Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy
    • Shinotoh, H. et al. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Ann. Neurol. 46, 62-69 (1999).
    • (1999) Ann. Neurol , vol.46 , pp. 62-69
    • Shinotoh, H.1
  • 11
    • 77955782898 scopus 로고    scopus 로고
    • Parkinson's disease symptoms: The patient's perspective
    • Politis, M. et al. Parkinson's disease symptoms: the patient's perspective. Mov. Disord. 25, 1646-1651 (2010).
    • (2010) Mov. Disord , vol.25 , pp. 1646-1651
    • Politis, M.1
  • 13
    • 84895853793 scopus 로고    scopus 로고
    • Dopamine receptor mapping with PET imaging in Parkinson's disease
    • Niccolini, F., Su, P. & Politis, M. Dopamine receptor mapping with PET imaging in Parkinson's disease. J. Neurol. http://dx.doi.org/10.1007/s00415-014-7302-2.
    • J. Neurol
    • Niccolini, F.1    Su, P.2    Politis, M.3
  • 14
    • 0032699176 scopus 로고    scopus 로고
    • Logistic discriminant parametric mapping: A novel method for the pixel-based differential diagnosis of Parkinson's disease
    • Acton, P. D., Mozley, P. D. & Kung, H. F. Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease. Eur. J. Nucl. Med. 26, 1413-1423 (1999).
    • (1999) Eur. J. Nucl. Med , vol.26 , pp. 1413-1423
    • Acton, P.D.1    Mozley, P.D.2    Kung, H.F.3
  • 15
    • 0032217111 scopus 로고    scopus 로고
    • [123I] β-CIT and SPECT in essential tremor and Parkinson's disease
    • Asenbaum, S. et al. [123I]β-CIT and SPECT in essential tremor and Parkinson's disease. J. Neural Transm. 105, 1213-1228 (1998).
    • (1998) J. Neural Transm , vol.105 , pp. 1213-1228
    • Asenbaum, S.1
  • 16
    • 0034029152 scopus 로고    scopus 로고
    • Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group
    • Benamer, T. S. et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov. Disord. 15, 503-510 (2000).
    • (2000) Mov. Disord , vol.15 , pp. 503-510
    • Benamer, T.S.1
  • 17
    • 0034727597 scopus 로고    scopus 로고
    • A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group
    • [No authors listed]
    • [No authors listed] A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group. Neurology 55, 1540-1547 (2000).
    • (2000) Neurology , vol.55 , pp. 1540-1547
  • 18
    • 0141502274 scopus 로고    scopus 로고
    • Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3-month observations
    • Benamer, H. T. et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov. Disord. 18, 977-984 (2003).
    • (2003) Mov. Disord , vol.18 , pp. 977-984
    • Benamer, H.T.1
  • 19
    • 0034761293 scopus 로고    scopus 로고
    • Quantitative analysis of striatal dopamine D2 receptors with 123I-iodolisuride SPECT in degenerative extrapyramidal diseases
    • Prunier, C. et al. Quantitative analysis of striatal dopamine D2 receptors with 123I-iodolisuride SPECT in degenerative extrapyramidal diseases. Nucl. Med. Commun. 22, 1207-1214 (2001).
    • (2001) Nucl. Med. Commun , vol.22 , pp. 1207-1214
    • Prunier, C.1
  • 20
    • 0035526277 scopus 로고    scopus 로고
    • [123I] β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy
    • Varrone, A. Marek, K. L., Jennings, D., Innis, R. B. & Seibyl, J. P. [123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov. Disord. 16, 1023-1032 (2001).
    • (2001) Mov. Disord , vol.16 , pp. 1023-1032
    • Varrone, A.1    Marek, K.L.2    Jennings, D.3    Innis, R.B.4    Seibyl, J.P.5
  • 21
    • 1842836514 scopus 로고    scopus 로고
    • Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand
    • Løkkegaard, A., Werdelin, L. M. & Friberg, L. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand. Eur. J. Nucl. Med. Mol. Imaging 29, 1623-1629 (2002).
    • (2002) Eur. J. Nucl. Med. Mol. Imaging , vol.29 , pp. 1623-1629
    • Løkkegaard, A.1    Werdelin, L.M.2    Friberg, L.3
  • 22
    • 0036561553 scopus 로고    scopus 로고
    • [123I] β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease
    • Gerschlager, W. et al. [123I]β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov. Disord. 17, 518-523 (2002).
    • (2002) Mov. Disord , vol.17 , pp. 518-523
    • Gerschlager, W.1
  • 23
    • 84862186620 scopus 로고    scopus 로고
    • The relationship between cerebral vascular disease and parkinsonism: The VADO study
    • Antonini, A. et al. The relationship between cerebral vascular disease and parkinsonism: the VADO study. Parkinsonism Relat. Disord. 18, 775-780 (2012).
    • (2012) Parkinsonism Relat. Disord , vol.18 , pp. 775-780
    • Antonini, A.1
  • 24
    • 34548224682 scopus 로고    scopus 로고
    • [123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson's disease
    • Zijlmans, J. et al. [123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson's disease. Mov. Disord. 22, 1278-85 (2007).
    • (2007) Mov. Disord , vol.22 , pp. 1278-1285
    • Zijlmans, J.1
  • 25
    • 84872677723 scopus 로고    scopus 로고
    • Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease
    • Benítez-Rivero, S. et al. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 84, 122-129 (2013).
    • (2013) J. Neurol. Neurosurg. Psychiatry , vol.84 , pp. 122-129
    • Benítez-Rivero, S.1
  • 26
    • 0025864333 scopus 로고
    • SPECT imaging of dopamine D2 receptors with 123I-IBZM: Initial experience in controls and patients with Parkinson's syndrome and Wilson's disease
    • Tatsch, K., Schwarz, J., Oertel, W. H. & Kirsch, C. M. SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease. Nucl. Med. Commun. 12, 699-707 (1991).
    • (1991) Nucl. Med. Commun , vol.12 , pp. 699-707
    • Tatsch, K.1    Schwarz, J.2    Oertel, W.H.3    Kirsch, C.M.4
  • 27
    • 0031594330 scopus 로고    scopus 로고
    • 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism
    • Schwarz, J. et al. 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism. Mov. Disord. 13, 16-19 (1998).
    • (1998) Mov. Disord , vol.13 , pp. 16-19
    • Schwarz, J.1
  • 28
    • 17844398549 scopus 로고    scopus 로고
    • Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: Study on 72 patients
    • Plotkin, M. et al. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J. Neural Transm. 112, 677-692 (2005).
    • (2005) J. Neural Transm , vol.112 , pp. 677-692
    • Plotkin, M.1
  • 29
    • 34248999903 scopus 로고    scopus 로고
    • Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism?
    • Koch, W., Hamann, C., Radau, P. E. & Tatsch, K. Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? Eur. J. Nucl. Med. Mol. Imaging 34, 1265-1273 (2007).
    • (2007) Eur. J. Nucl. Med. Mol. Imaging , vol.34 , pp. 1265-1273
    • Koch, W.1    Hamann, C.2    Radau, P.E.3    Tatsch, K.4
  • 30
    • 79955756270 scopus 로고    scopus 로고
    • Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: A multidimensional statistical approach
    • Südmeyer, M. et al. Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach. J. Nucl. Med. 52, 733-740 (2011).
    • (2011) J. Nucl. Med , vol.52 , pp. 733-740
    • Südmeyer, M.1
  • 31
    • 84867507249 scopus 로고    scopus 로고
    • [18F] FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism
    • Hellwig, S. et al. [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 79, 1314-1322 (2012).
    • (2012) Neurology , vol.79 , pp. 1314-1322
    • Hellwig, S.1
  • 32
    • 35948961138 scopus 로고    scopus 로고
    • Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes
    • Vlaar, A. M., van Kroonenburgh, M. J., Kessels, A. G. & Weber, W. E. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes. BMC Neurol. 7, 27 (2007).
    • (2007) BMC Neurol , vol.7 , pp. 27
    • Vlaar, A.M.1    Van Kroonenburgh, M.J.2    Kessels, A.G.3    Weber, W.E.4
  • 33
    • 0242288107 scopus 로고    scopus 로고
    • Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: A decision-analytic approach
    • Dodel, R. C. et al. Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach. Mov. Disord. 18, S52-S62 (2003).
    • (2003) Mov. Disord , vol.18 , pp. S52-S62
    • Dodel, R.C.1
  • 34
    • 57749208525 scopus 로고    scopus 로고
    • Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy
    • Antonini, A. et al. Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy. Mov. Disord. 23, 2202-2209 (2008).
    • (2008) Mov. Disord , vol.23 , pp. 2202-2209
    • Antonini, A.1
  • 35
    • 0033933435 scopus 로고    scopus 로고
    • Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers
    • Lavalaye, J., Booij, J., Reneman, L., Habraken, J. B. & van Royen, E. A. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur. J. Nucl. Med. 27, 867-869 (2000).
    • (2000) Eur. J. Nucl. Med , vol.27 , pp. 867-869
    • Lavalaye, J.1    Booij, J.2    Reneman, L.3    Habraken, J.B.4    Van Royen, E.A.5
  • 36
    • 33646459451 scopus 로고    scopus 로고
    • A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil
    • van Dyck, C. H. et al. A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil. Am. J. Geriatr. Psychiatry 14, 428-437 (2006).
    • (2006) Am. J. Geriatr. Psychiatry , vol.14 , pp. 428-437
    • Van Dyck, C.H.1
  • 37
    • 0028219583 scopus 로고
    • Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: Discriminant analysis of striatal 18F-dopa PET data
    • Burn, D. J., Sawle, G. V. & Brooks, D. J. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J. Neurol. Neurosurg. Psychiatry 57, 278-284 (1994).
    • (1994) J. Neurol. Neurosurg. Psychiatry , vol.57 , pp. 278-284
    • Burn, D.J.1    Sawle, G.V.2    Brooks, D.J.3
  • 38
    • 0028271363 scopus 로고
    • Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data
    • Sawle, G. V., Playford, E. D., Burn, D. J., Cunningham, V. J. & Brooks, D. J. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data. Arch. Neurol. 51, 237-243 (1994).
    • (1994) Arch. Neurol , vol.51 , pp. 237-243
    • Sawle, G.V.1    Playford, E.D.2    Burn, D.J.3    Cunningham, V.J.4    Brooks, D.J.5
  • 39
    • 3943053477 scopus 로고    scopus 로고
    • The dopamine D2 receptor ligand 18F-desmethoxy-fallypride: An appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism
    • Schreckenberger, M. et al. The dopamine D2 receptor ligand 18F-desmethoxy-fallypride: an appropriate fluorinated PET tracer for the differential diagnosis of parkinsonism. Eur. J. Nucl. Med. Mol. Imaging 31, 1128-1135 (2004).
    • (2004) Eur. J. Nucl. Med. Mol. Imaging , vol.31 , pp. 1128-1135
    • Schreckenberger, M.1
  • 40
    • 84874222032 scopus 로고    scopus 로고
    • Differential diagnosis of Parkinsonism using dual-phase F-18 FP-CIT PET imaging
    • Jin, S. et al. Differential diagnosis of Parkinsonism using dual-phase F-18 FP-CIT PET imaging. Nucl. Med. Mol. Imaging 47, 44-51 (2013).
    • (2013) Nucl. Med. Mol. Imaging , vol.47 , pp. 44-51
    • Jin, S.1
  • 41
    • 10344229443 scopus 로고    scopus 로고
    • Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET
    • Ishikawa, T. et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET. J. Nucl. Med. 37, 1760-1765 (1996).
    • (1996) J. Nucl. Med , vol.37 , pp. 1760-1765
    • Ishikawa, T.1
  • 42
    • 31444451405 scopus 로고    scopus 로고
    • Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease
    • Eshuis, S. A., Maguire, R. P., Leenders, K. L., Jonkman, S. & Jager, P. L. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease. Eur. J. Nucl. Med. Mol. Imaging 33, 200-209 (2006).
    • (2006) Eur. J. Nucl. Med. Mol. Imaging , vol.33 , pp. 200-209
    • Eshuis, S.A.1    Maguire, R.P.2    Leenders, K.L.3    Jonkman, S.4    Jager, P.L.5
  • 43
    • 3843060242 scopus 로고    scopus 로고
    • Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET
    • Juh, R., Kim, J., Moon, D., Choe, B. & Suh, T. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. Eur. J. Radiol. 51, 223-233 (2004).
    • (2004) Eur. J. Radiol , vol.51 , pp. 223-233
    • Juh, R.1    Kim, J.2    Moon, D.3    Choe, B.4    Suh, T.5
  • 44
    • 0029401262 scopus 로고
    • Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography
    • Eidelberg, D. et al. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology 45, 1995-2004 (1995).
    • (1995) Neurology , vol.45 , pp. 1995-2004
    • Eidelberg, D.1
  • 45
    • 20444436869 scopus 로고    scopus 로고
    • FDG PET in the differential diagnosis of parkinsonian disorders
    • Eckert, T. et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26, 912-921 (2005).
    • (2005) Neuroimage , vol.26 , pp. 912-921
    • Eckert, T.1
  • 46
    • 84876143207 scopus 로고    scopus 로고
    • Validation of parkinsonian disease-related metabolic brain patterns
    • Teune, L. K. et al. Validation of parkinsonian disease-related metabolic brain patterns. Mov. Disord. 28, 547-551 (2013).
    • (2013) Mov. Disord , vol.28 , pp. 547-551
    • Teune, L.K.1
  • 47
    • 76249130565 scopus 로고    scopus 로고
    • Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis
    • Tang, C. C. et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 9, 149-158 (2010).
    • (2010) Lancet Neurol , vol.9 , pp. 149-158
    • Tang, C.C.1
  • 48
    • 16444384151 scopus 로고    scopus 로고
    • Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective
    • Moulin-Romsee, G., Maes, A., Silverman, D., Mortelmans, L. & Van Laere, K. Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective. Eur. J. Neurol. 12, 254-63 (2005).
    • (2005) Eur. J. Neurol , vol.12 , pp. 254-263
    • Moulin-Romsee, G.1    Maes, A.2    Silverman, D.3    Mortelmans, L.4    Van Laere, K.5
  • 49
    • 0036120810 scopus 로고    scopus 로고
    • Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease
    • Righini, A. et al. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J. Comput. Assist. Tomogr. 26, 266-271 (2002).
    • (2002) J. Comput. Assist. Tomogr , vol.26 , pp. 266-271
    • Righini, A.1
  • 50
    • 70349651971 scopus 로고    scopus 로고
    • Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort
    • Linder, J. et al. Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort. J. Neurol. 256, 1671-1680 (2009).
    • (2009) J. Neurol , vol.256 , pp. 1671-1680
    • Linder, J.1
  • 51
    • 5644288451 scopus 로고    scopus 로고
    • Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease
    • Price, S. et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 23, 663-669 (2004).
    • (2004) Neuroimage , vol.23 , pp. 663-669
    • Price, S.1
  • 52
    • 13844314087 scopus 로고    scopus 로고
    • Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy
    • Paviour, D. C., Price, S. L., Stevens, J. M., Lees, A. J. & Fox, N. C. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 64, 675-679 (2005).
    • (2005) Neurology , vol.64 , pp. 675-679
    • Paviour, D.C.1    Price, S.L.2    Stevens, J.M.3    Lees, A.J.4    Fox, N.C.5
  • 53
    • 84876522550 scopus 로고    scopus 로고
    • Differential diagnosis tool for parkinsonian syndrome using multiple structural brain measures
    • Ota, M. et al. Differential diagnosis tool for parkinsonian syndrome using multiple structural brain measures. Comput. Math. Methods Med. 2013, 571289 (2013).
    • (2013) Comput. Math. Methods Med , vol.2013 , pp. 571289
    • Ota, M.1
  • 54
    • 84880293475 scopus 로고    scopus 로고
    • Automated, high accuracy classification of Parkinsonian disorders: A pattern recognition approach
    • Marquand, A. F. et al. Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach. PLoS ONE 8, e69237 (2013).
    • (2013) PLoS ONE , vol.8
    • Marquand, A.F.1
  • 55
    • 0037176815 scopus 로고    scopus 로고
    • Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD
    • Schocke, M. F. et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58, 575-580 (2002).
    • (2002) Neurology , vol.58 , pp. 575-580
    • Schocke, M.F.1
  • 56
    • 0037465774 scopus 로고    scopus 로고
    • Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy
    • Seppi, K. et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 60, 922-927 (2003).
    • (2003) Neurology , vol.60 , pp. 922-927
    • Seppi, K.1
  • 57
    • 84920945580 scopus 로고    scopus 로고
    • Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease
    • Weiduschat, N. et al. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease. J. Neuroimaging http://dx.doi.org/10.1111/jon.12074.
    • J. Neuroimaging
    • Weiduschat, N.1
  • 58
    • 0034935922 scopus 로고    scopus 로고
    • Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings
    • Berg, D., Siefker, C. & Becker, G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J. Neurol. 248, 684-689 (2001).
    • (2001) J. Neurol , vol.248 , pp. 684-689
    • Berg, D.1    Siefker, C.2    Becker, G.3
  • 59
    • 0037435514 scopus 로고    scopus 로고
    • Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes
    • Walter, U. et al. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 60, 74-77 (2003).
    • (2003) Neurology , vol.60 , pp. 74-77
    • Walter, U.1
  • 60
    • 3543098625 scopus 로고    scopus 로고
    • Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy
    • Walter, U. et al. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 63, 504-509 (2004).
    • (2004) Neurology , vol.63 , pp. 504-509
    • Walter, U.1
  • 61
    • 41949137200 scopus 로고    scopus 로고
    • The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: A prospective blinded study
    • Gaenslen, A. et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol. 7, 417-424 (2008).
    • (2008) Lancet Neurol , vol.7 , pp. 417-424
    • Gaenslen, A.1
  • 62
    • 84899977467 scopus 로고    scopus 로고
    • Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: A head-to-head comparison
    • Hellwig, S. et al. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison. Eur. J. Neurol. 21, 860-866 (2014).
    • (2014) Eur. J. Neurol , vol.21 , pp. 860-866
    • Hellwig, S.1
  • 63
    • 84877707641 scopus 로고    scopus 로고
    • Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: Prospective cohort study in 196 patients
    • Bouwmans, A. E., Vlaar, A. M., Mess, W. H., Kessels, A. & Weber, W. E. Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients. BMJ Open 3, e002613 (2013).
    • (2013) BMJ Open , vol.3
    • Bouwmans, A.E.1    Vlaar, A.M.2    Mess, W.H.3    Kessels, A.4    Weber, W.E.5
  • 64
    • 0035412899 scopus 로고    scopus 로고
    • Rate of progression in Parkinson's disease: A 6-[18F]fluoro-l-dopa PET study
    • Nurmi, E. et al. Rate of progression in Parkinson's disease: a 6-[18F]fluoro-l-dopa PET study. Mov. Disord. 16, 608-615 (2001).
    • (2001) Mov. Disord , vol.16 , pp. 608-615
    • Nurmi, E.1
  • 65
    • 79955484858 scopus 로고    scopus 로고
    • Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study
    • Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L. & Brooks, D. J. Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study. Neuroimage 56, 1463-1468 (2011).
    • (2011) Neuroimage , vol.56 , pp. 1463-1468
    • Pavese, N.1    Rivero-Bosch, M.2    Lewis, S.J.3    Whone, A.L.4    Brooks, D.J.5
  • 66
    • 67651177750 scopus 로고    scopus 로고
    • A follow-up study on 6-[18F]fluoro-l-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen
    • Brück, A. et al. A follow-up study on 6-[18F]fluoro-l-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen. Mov. Disord. 24, 1009-1015 (2009).
    • (2009) Mov. Disord , vol.24 , pp. 1009-1015
    • Brück, A.1
  • 67
    • 70350678559 scopus 로고    scopus 로고
    • Longitudinal progression of sporadic Parkinson's disease: A multi-tracer positron emission tomography study
    • Nandhagopal, R. et al. Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain 132, 2970-2979 (2009).
    • (2009) Brain , vol.132 , pp. 2970-2979
    • Nandhagopal, R.1
  • 68
    • 14844300111 scopus 로고    scopus 로고
    • Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity
    • Hilker, R. et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch. Neurol. 62, 378-382 (2005).
    • (2005) Arch. Neurol , vol.62 , pp. 378-382
    • Hilker, R.1
  • 69
    • 18844471416 scopus 로고    scopus 로고
    • In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
    • Lee, C. S. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann. Neurol. 47, 493-503 (2000).
    • (2000) Ann. Neurol , vol.47 , pp. 493-503
    • Lee, C.S.1
  • 70
    • 79955466566 scopus 로고    scopus 로고
    • Age-specific progression of nigrostriatal dysfunction in Parkinson's disease
    • de la Fuente-Fernández, R. et al. Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Ann. Neurol. 69, 803-810 (2011).
    • (2011) Ann. Neurol , vol.69 , pp. 803-810
    • De La Fuente-Fernández, R.1
  • 71
    • 0025065388 scopus 로고
    • Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
    • Brooks, D. J. et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Ann. Neurol. 28, 547-555 (1990).
    • (1990) Ann. Neurol , vol.28 , pp. 547-555
    • Brooks, D.J.1
  • 72
    • 34447636064 scopus 로고    scopus 로고
    • Changes in network activity with the progression of Parkinson's disease
    • Huang, C. et al. Changes in network activity with the progression of Parkinson's disease. Brain 130, 1834-1846 (2007).
    • (2007) Brain , vol.130 , pp. 1834-1846
    • Huang, C.1
  • 73
    • 75749128636 scopus 로고    scopus 로고
    • Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease
    • Tang, C. C., Poston, K. L., Dhawan, V. & Eidelberg, D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J. Neurosci. 30, 1049-1056 (2010).
    • (2010) J. Neurosci , vol.30 , pp. 1049-1056
    • Tang, C.C.1    Poston, K.L.2    Dhawan, V.3    Eidelberg, D.4
  • 74
    • 84871724455 scopus 로고    scopus 로고
    • Progression of cortical thinning in early Parkinson's disease
    • Ibarretxe-Bilbao, N. et al. Progression of cortical thinning in early Parkinson's disease. Mov. Disord. 27, 1746-1753 (2012).
    • (2012) Mov. Disord , vol.27 , pp. 1746-1753
    • Ibarretxe-Bilbao, N.1
  • 75
    • 84855428685 scopus 로고    scopus 로고
    • Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI
    • Fernández-Seara, M. A. et al. Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI. Neuroimage 59, 2743-2750 (2012).
    • (2012) Neuroimage , vol.59 , pp. 2743-2750
    • Fernández-Seara, M.A.1
  • 76
    • 84871754989 scopus 로고    scopus 로고
    • Resting state functional connectivity of the striatum in Parkinson's disease
    • Hacker, C. D., Perlmutter, J. S., Criswell, S. R., Ances, B. M. & Snyder, A. Z. Resting state functional connectivity of the striatum in Parkinson's disease. Brain 135, 3699-3711 (2012).
    • (2012) Brain , vol.135 , pp. 3699-3711
    • Hacker, C.D.1    Perlmutter, J.S.2    Criswell, S.R.3    Ances, B.M.4    Snyder, A.Z.5
  • 77
    • 84876330064 scopus 로고    scopus 로고
    • Diffusion tensor imaging in parkinsonian syndromes: A systematic review and meta-analysis
    • Cochrane, C. J. & Ebmeier, K. P. Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology 80, 857-864 (2013).
    • (2013) Neurology , vol.80 , pp. 857-864
    • Cochrane, C.J.1    Ebmeier, K.P.2
  • 78
    • 77955905072 scopus 로고    scopus 로고
    • Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study
    • Zhang, J. et al. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res. 1330, 124-130 (2010).
    • (2010) Brain Res , vol.1330 , pp. 124-130
    • Zhang, J.1
  • 79
    • 84876412536 scopus 로고    scopus 로고
    • Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging
    • Ohtsuka, C. et al. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci. Lett. 541, 93-98 (2013).
    • (2013) Neurosci. Lett , vol.541 , pp. 93-98
    • Ohtsuka, C.1
  • 80
    • 0030614902 scopus 로고    scopus 로고
    • [123I] FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease
    • Booij, J. et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 62, 133-140 (1997).
    • (1997) J. Neurol. Neurosurg. Psychiatry , vol.62 , pp. 133-140
    • Booij, J.1
  • 81
    • 0035846468 scopus 로고    scopus 로고
    • [123I] β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression
    • Marek, K. et al. [123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 57, 2089-2094 (2001).
    • (2001) Neurology , vol.57 , pp. 2089-2094
    • Marek, K.1
  • 82
    • 0029670370 scopus 로고    scopus 로고
    • Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: Correlations with the three main symptoms
    • Otsuka, M. et al. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms. J. Neurol. Sci. 136, 169-173 (1996).
    • (1996) J. Neurol. Sci , vol.136 , pp. 169-173
    • Otsuka, M.1
  • 83
    • 1842290405 scopus 로고    scopus 로고
    • Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
    • Vingerhoets, F. J., Schulzer, M., Calne, D. B. & Snow, B. J. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann. Neurol. 41, 58-64 (1997).
    • (1997) Ann. Neurol , vol.41 , pp. 58-64
    • Vingerhoets, F.J.1    Schulzer, M.2    Calne, D.B.3    Snow, B.J.4
  • 84
    • 0032776109 scopus 로고    scopus 로고
    • The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease
    • Broussolle, E. et al. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J. Neurol. Sci. 166, 141-151 (1999).
    • (1999) J. Neurol. Sci , vol.166 , pp. 141-151
    • Broussolle, E.1
  • 85
    • 84902206494 scopus 로고    scopus 로고
    • Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography
    • Hsiao, I. T. et al. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. JAMA Neurol. 71, 758-766 (2014).
    • (2014) JAMA Neurol , vol.71 , pp. 758-766
    • Hsiao, I.T.1
  • 86
    • 33750975077 scopus 로고    scopus 로고
    • Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study
    • Pavese, N. et al. Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study. Neurology 67, 1612-1617 (2006).
    • (2006) Neurology , vol.67 , pp. 1612-1617
    • Pavese, N.1
  • 87
    • 84896751626 scopus 로고    scopus 로고
    • Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients
    • Politis, M. et al. Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. J. Clin. Invest. 124, 1340-1349 (2014).
    • (2014) J. Clin. Invest , vol.124 , pp. 1340-1349
    • Politis, M.1
  • 88
    • 84872525238 scopus 로고    scopus 로고
    • Differences in brain activation between tremor- and nontremor-dominant Parkinson disease
    • Prodoehl, J. et al. Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. JAMA Neurol. 70, 100-106 (2013).
    • (2013) JAMA Neurol , vol.70 , pp. 100-106
    • Prodoehl, J.1
  • 89
    • 0037465371 scopus 로고    scopus 로고
    • Tremor in Parkinson's disease and serotonergic dysfunction: An 11C-WAY 100635 PET study
    • Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J. & Brooks, D. J. Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology 60, 601-605 (2003).
    • (2003) Neurology , vol.60 , pp. 601-605
    • Doder, M.1    Rabiner, E.A.2    Turjanski, N.3    Lees, A.J.4    Brooks, D.J.5
  • 90
    • 0026767497 scopus 로고
    • Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study
    • Brooks, D. J. et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 42, 1554-1560 (1992).
    • (1992) Neurology , vol.42 , pp. 1554-1560
    • Brooks, D.J.1
  • 91
    • 0033955756 scopus 로고    scopus 로고
    • Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
    • de la Fuente-Fernández, R. et al. Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations. J. Neural Transm. 107, 49-57 (2000).
    • (2000) J. Neural Transm , vol.107 , pp. 49-57
    • De La Fuente-Fernández, R.1
  • 92
    • 84879112972 scopus 로고    scopus 로고
    • Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD
    • Loane, C. et al. Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD. Neurology 80, 1850-1855 (2013).
    • (2013) Neurology , vol.80 , pp. 1850-1855
    • Loane, C.1
  • 93
    • 73449090105 scopus 로고    scopus 로고
    • History of falls in Parkinson disease is associated with reduced cholinergic activity
    • Bohnen, N. I. et al. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 73, 1670-1676 (2009).
    • (2009) Neurology , vol.73 , pp. 1670-1676
    • Bohnen, N.I.1
  • 94
    • 0034167437 scopus 로고    scopus 로고
    • The pedunculopontine nucleus: Its role in the genesis of movement disorders
    • Lee, M. S., Rinne, J. O. & Marsden, C. D. The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med. J. 41, 167-184 (2000).
    • (2000) Yonsei Med. J , vol.41 , pp. 167-184
    • Lee, M.S.1    Rinne, J.O.2    Marsden, C.D.3
  • 95
    • 84867772010 scopus 로고    scopus 로고
    • Regional gray matter atrophy in patients with Parkinson disease and freezing of gait
    • Tessitore, A. et al. Regional gray matter atrophy in patients with Parkinson disease and freezing of gait. AJNR Am. J. Neuroradiol. 33, 1804-1809 (2012).
    • (2012) AJNR Am. J. Neuroradiol , vol.33 , pp. 1804-1809
    • Tessitore, A.1
  • 96
    • 84858130465 scopus 로고    scopus 로고
    • Pattern of brain tissue loss associated with freezing of gait in Parkinson disease
    • Kostic, V. S. et al. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology 78, 409-416 (2012).
    • (2012) Neurology , vol.78 , pp. 409-416
    • Kostic, V.S.1
  • 97
    • 84876037711 scopus 로고    scopus 로고
    • Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease
    • Shine, J. M. et al. Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease. Brain 136, 1204-1215 (2013).
    • (2013) Brain , vol.136 , pp. 1204-1215
    • Shine, J.M.1
  • 98
    • 33750315667 scopus 로고    scopus 로고
    • Striatal dopa and glucose metabolism in PD patients with freezing of gait
    • Bartels, A. L. et al. Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov. Disord. 21, 1326-1332 (2006).
    • (2006) Mov. Disord , vol.21 , pp. 1326-1332
    • Bartels, A.L.1
  • 99
    • 84897957033 scopus 로고    scopus 로고
    • Dyskinesias in Parkinson's disease: Views from positron emission tomography studies
    • Niccolini, F., Loane, C. & Politis, M. Dyskinesias in Parkinson's disease: views from positron emission tomography studies. Eur. J. Neurol. 21, 694-699 (2014).
    • (2014) Eur. J. Neurol , vol.21 , pp. 694-699
    • Niccolini, F.1    Loane, C.2    Politis, M.3
  • 100
    • 65249107128 scopus 로고    scopus 로고
    • PET demonstrates reduced dopamine transporter expression in PD with dyskinesias
    • Troiano, A. R., de la Fuente-Fernández, R. & Sossi, V. PET demonstrates reduced dopamine transporter expression in PD with dyskinesias. Neurology 72, 1211-1216 (2009).
    • (2009) Neurology , vol.72 , pp. 1211-1216
    • Troiano, A.R.1    De La Fuente-Fernández, R.2    Sossi, V.3
  • 101
    • 0035092779 scopus 로고    scopus 로고
    • Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover
    • de la Fuente-Fernández, R. et al. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Ann. Neurol. 49, 298-303 (2001).
    • (2001) Ann. Neurol , vol.49 , pp. 298-303
    • De La Fuente-Fernández, R.1
  • 102
    • 10344236071 scopus 로고    scopus 로고
    • Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: Implications for dyskinesias
    • de la Fuente- Fernández, R. et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 127, 2747-2754 (2004).
    • (2004) Brain , vol.127 , pp. 2747-2754
    • De La Fuente-Fernández, R.1
  • 103
    • 34247262201 scopus 로고    scopus 로고
    • Reduced substance P binding in Parkinson's disease complicated by dyskinesias: An F-18-L829165 PET study
    • Whone, A. L. et al. Reduced substance P binding in Parkinson's disease complicated by dyskinesias: an F-18-L829165 PET study. Neurology 58 (Suppl. 3), A488-A449 (2002).
    • (2002) Neurology , vol.58 , pp. A488-A449
    • Whone, A.L.1
  • 104
    • 79958163183 scopus 로고    scopus 로고
    • Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
    • Ramlackhansingh, A. F. et al. Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease. Neurology 76, 1811-1816 (2011).
    • (2011) Neurology , vol.76 , pp. 1811-1816
    • Ramlackhansingh, A.F.1
  • 105
    • 79952234223 scopus 로고    scopus 로고
    • Adenosine A2A receptors measured with [11C]TMSX PET in the striata of Parkinson's Disease patients
    • Mishina, M. et al. Adenosine A2A receptors measured with [11C]TMSX PET in the striata of Parkinson's Disease patients. PLoS ONE 6, e17338 (2011).
    • (2011) PLoS ONE , vol.6
    • Mishina, M.1
  • 106
    • 79953647380 scopus 로고    scopus 로고
    • Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias
    • Ahmed, I. et al. Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias. Brain 134, 979-986 (2011).
    • (2011) Brain , vol.134 , pp. 979-986
    • Ahmed, I.1
  • 107
    • 32544432029 scopus 로고    scopus 로고
    • Non-motor symptoms of Parkinson's disease: Diagnosis and management
    • Chaudhuri, K. R., Healy, D. G. & Schapira, A. H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 5, 235-245 (2006).
    • (2006) Lancet Neurol , vol.5 , pp. 235-245
    • Chaudhuri, K.R.1    Healy, D.G.2    Schapira, A.H.3
  • 108
    • 54049120959 scopus 로고    scopus 로고
    • Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study
    • Politis, M., Piccini, P., Pavese, N., Koh, S. B. & Brooks, D. J. Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study. Exp. Neurol. 214, 112-116 (2008).
    • (2008) Exp. Neurol , vol.214 , pp. 112-116
    • Politis, M.1    Piccini, P.2    Pavese, N.3    Koh, S.B.4    Brooks, D.J.5
  • 109
    • 84859496019 scopus 로고    scopus 로고
    • Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts
    • Politis, M. et al. Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Sci. Transl. Med. 4, 128ra41 (2012).
    • (2012) Sci. Transl. Med , vol.4
    • Politis, M.1
  • 110
    • 0036589970 scopus 로고    scopus 로고
    • Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease
    • Burn, D. J. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease. Mov. Disord. 17, 445-454 (2002).
    • (2002) Mov. Disord , vol.17 , pp. 445-454
    • Burn, D.J.1
  • 111
    • 20444477480 scopus 로고    scopus 로고
    • Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system
    • Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128, 1314-1322 (2005).
    • (2005) Brain , vol.128 , pp. 1314-1322
    • Remy, P.1    Doder, M.2    Lees, A.3    Turjanski, N.4    Brooks, D.5
  • 112
    • 0000296112 scopus 로고    scopus 로고
    • Brain serotonin HT1A receptors in Parkinson's disease with and without depression measured by positron emission tomography and 11C-WAY100635
    • Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J. & Brooks, D. J. Brain serotonin HT1A receptors in Parkinson's disease with and without depression measured by positron emission tomography and 11C-WAY100635. Mov. Disord. 15 (Suppl. 3), 213 (2000).
    • (2000) Mov. Disord , vol.15 , pp. 213
    • Doder, M.1    Rabiner, E.A.2    Turjanski, N.3    Lees, A.J.4    Brooks, D.J.5
  • 113
    • 57049114907 scopus 로고    scopus 로고
    • Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB
    • Boileau, I. et al. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Mov. Disord. 23, 1776-1780 (2008).
    • (2008) Mov. Disord , vol.23 , pp. 1776-1780
    • Boileau, I.1
  • 114
    • 78650030521 scopus 로고    scopus 로고
    • Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures
    • Politis, M. et al. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 75, 1920-1927 (2010).
    • (2010) Neurology , vol.75 , pp. 1920-1927
    • Politis, M.1
  • 115
    • 84855920924 scopus 로고    scopus 로고
    • Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease
    • Ballanger, B. et al. Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease. Mov. Disord. 27, 84-89 (2012).
    • (2012) Mov. Disord , vol.27 , pp. 84-89
    • Ballanger, B.1
  • 116
    • 11444270248 scopus 로고    scopus 로고
    • Hallucinations and sleep disorders in PD: Six-year prospective longitudinal study
    • Goetz, C. G., Wuu, J., Curgian, L. M. & Leurgans, S. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology 64, 81-86 (2005).
    • (2005) Neurology , vol.64 , pp. 81-86
    • Goetz, C.G.1    Wuu, J.2    Curgian, L.M.3    Leurgans, S.4
  • 117
    • 0041883808 scopus 로고    scopus 로고
    • [18F] fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease
    • Hilker, R. et al. [18F]fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson's disease. Clin. Neurol. Neurosurg. 105, 262-269 (2003).
    • (2003) Clin. Neurol. Neurosurg , vol.105 , pp. 262-269
    • Hilker, R.1
  • 118
    • 84860122434 scopus 로고    scopus 로고
    • Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease
    • Kotagal, V. et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann. Neurol. 71, 560-568 (2012).
    • (2012) Ann. Neurol , vol.71 , pp. 560-568
    • Kotagal, V.1
  • 119
    • 84863630897 scopus 로고    scopus 로고
    • The role of serotonin in sleep disordered breathing associated with Parkinson disease: A correlative [11C]DASB PET imaging study
    • Lelieveld, I. M. et al. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. PLoS ONE 7, e40166 (2012).
    • (2012) PLoS ONE , vol.7
    • Lelieveld, I.M.1
  • 120
    • 0036836047 scopus 로고    scopus 로고
    • Measuring fatigue in patients with Parkinson's disease - The Fatigue Severity Scale
    • Herlofson, K. & Larsen, J. P. Measuring fatigue in patients with Parkinson's disease-the Fatigue Severity Scale. Eur. J. Neurol. 9, 595-600 (2002).
    • (2002) Eur. J. Neurol , vol.9 , pp. 595-600
    • Herlofson, K.1    Larsen, J.P.2
  • 121
    • 78049460075 scopus 로고    scopus 로고
    • Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
    • Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R. & Brooks, D. J. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 133, 3434-3443 (2010).
    • (2010) Brain , vol.133 , pp. 3434-3443
    • Pavese, N.1    Metta, V.2    Bose, S.K.3    Chaudhuri, K.R.4    Brooks, D.J.5
  • 123
    • 79960250055 scopus 로고    scopus 로고
    • Serotonergic mediated body mass index changes in Parkinson's disease
    • Politis, M., Loane, C., Wu, K., Brooks, D. J. & Piccini, P. Serotonergic mediated body mass index changes in Parkinson's disease. Neurobiol. Dis. 43, 609-615 (2011).
    • (2011) Neurobiol. Dis , vol.43 , pp. 609-615
    • Politis, M.1    Loane, C.2    Wu, K.3    Brooks, D.J.4    Piccini, P.5
  • 124
    • 77950894522 scopus 로고    scopus 로고
    • Serotonin 2A receptors and visual hallucinations in Parkinson disease
    • Ballanger, B. et al. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch. Neurol. 67, 416-421 (2010).
    • (2010) Arch. Neurol , vol.67 , pp. 416-421
    • Ballanger, B.1
  • 125
    • 4344644880 scopus 로고    scopus 로고
    • Visual hallucination in Parkinson's disease with FDG PET
    • Nagano-Saito, A. et al. Visual hallucination in Parkinson's disease with FDG PET. Mov. Disord. 19, 801-806 (2004).
    • (2004) Mov. Disord , vol.19 , pp. 801-806
    • Nagano-Saito, A.1
  • 126
    • 32044447659 scopus 로고    scopus 로고
    • An estimate of the worldwide prevalence and direct costs of dementia in 2003
    • Wimo, A., Jonsson, L. & Winblad, B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement. Geriatr. Cogn. Disord. 21, 175-181 (2006).
    • (2006) Dement. Geriatr. Cogn. Disord , vol.21 , pp. 175-181
    • Wimo, A.1    Jonsson, L.2    Winblad, B.3
  • 127
    • 73249142830 scopus 로고    scopus 로고
    • Parkinson disease and impulse control disorders: A review of clinical features, pathophysiology and management
    • Wu, K., Politis, M. & Piccini, P. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad. Med. J. 85, 590-596 (2009).
    • (2009) Postgrad. Med. J , vol.85 , pp. 590-596
    • Wu, K.1    Politis, M.2    Piccini, P.3
  • 128
  • 129
    • 33646358930 scopus 로고    scopus 로고
    • Compulsive drug use linked to sensitized ventral striatal dopamine transmission
    • Evans, A. H. et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann. Neurol. 59, 852-858 (2006).
    • (2006) Ann. Neurol , vol.59 , pp. 852-858
    • Evans, A.H.1
  • 130
    • 79953658757 scopus 로고    scopus 로고
    • Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours
    • O'Sullivan, S. S. et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 134, 969-978 (2011).
    • (2011) Brain , vol.134 , pp. 969-978
    • O'Sullivan, S.S.1
  • 131
    • 66549083459 scopus 로고    scopus 로고
    • Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A [11C] raclopride PET study
    • Steeves, T. D. et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132, 1376-1385 (2009).
    • (2009) Brain , vol.132 , pp. 1376-1385
    • Steeves, T.D.1
  • 132
    • 78649506636 scopus 로고    scopus 로고
    • Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD
    • van Eimeren, T. et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 75, 1711-1716 (2010).
    • (2010) Neurology , vol.75 , pp. 1711-1716
    • Van Eimeren, T.1
  • 133
    • 84874341545 scopus 로고    scopus 로고
    • Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease
    • Politis, M. et al. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease. Brain 136, 400-411 (2013).
    • (2013) Brain , vol.136 , pp. 400-411
    • Politis, M.1
  • 134
    • 27844469751 scopus 로고    scopus 로고
    • A systematic review of prevalence studies of dementia in Parkinson's disease
    • Aarsland, D., Zaccai, J. & Brayne, C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov. Disord. 20, 1255-1263 (2005).
    • (2005) Mov. Disord , vol.20 , pp. 1255-1263
    • Aarsland, D.1    Zaccai, J.2    Brayne, C.3
  • 135
    • 41149173996 scopus 로고    scopus 로고
    • The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
    • Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M. & Morris, J. G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837-844 (2008).
    • (2008) Mov. Disord , vol.23 , pp. 837-844
    • Hely, M.A.1    Reid, W.G.2    Adena, M.A.3    Halliday, G.M.4    Morris, J.G.5
  • 136
    • 0006164301 scopus 로고    scopus 로고
    • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
    • McKeith, I. G. et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 1113-1124 (1996).
    • (1996) Neurology , vol.47 , pp. 1113-1124
    • McKeith, I.G.1
  • 137
    • 33144489150 scopus 로고    scopus 로고
    • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
    • McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863-1872 (2005).
    • (2005) Neurology , vol.65 , pp. 1863-1872
    • McKeith, I.G.1
  • 138
    • 0042970162 scopus 로고    scopus 로고
    • Dementia associated with Parkinson's disease
    • Emre, M. Dementia associated with Parkinson's disease. Lancet Neurol. 2, 229-237 (2003).
    • (2003) Lancet Neurol , vol.2 , pp. 229-237
    • Emre, M.1
  • 139
    • 84864698964 scopus 로고    scopus 로고
    • The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: A PET study
    • Wu, K. et al. The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study. Brain 135, 2449-2457 (2012).
    • (2012) Brain , vol.135 , pp. 2449-2457
    • Wu, K.1
  • 140
    • 0036260184 scopus 로고    scopus 로고
    • Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-l-dopa PET study
    • Ito, K. et al. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-l-dopa PET study. Brain 125, 1358-1365 (2002).
    • (2002) Brain , vol.125 , pp. 1358-1365
    • Ito, K.1
  • 141
    • 2942586799 scopus 로고    scopus 로고
    • Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies
    • Nagano-Saito, A. et al. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage 22, 553-561 (2004).
    • (2004) Neuroimage , vol.22 , pp. 553-561
    • Nagano-Saito, A.1
  • 142
    • 33645078446 scopus 로고    scopus 로고
    • Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways
    • Hilker, R. et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65, 1716-1722 (2005).
    • (2005) Neurology , vol.65 , pp. 1716-1722
    • Hilker, R.1
  • 143
    • 77950511411 scopus 로고    scopus 로고
    • Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo
    • Klein, J. C. et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74, 885-892 (2010).
    • (2010) Neurology , vol.74 , pp. 885-892
    • Klein, J.C.1
  • 144
    • 79960197365 scopus 로고    scopus 로고
    • In vivo assessment of vesicular monoamine transporter type 2 in dementia with Lewy bodies and Alzheimer disease
    • Villemagne, V. L. et al. In vivo assessment of vesicular monoamine transporter type 2 in dementia with Lewy bodies and Alzheimer disease. Arch. Neurol. 68, 905-912 (2011).
    • (2011) Arch. Neurol , vol.68 , pp. 905-912
    • Villemagne, V.L.1
  • 145
    • 2342555065 scopus 로고    scopus 로고
    • Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison
    • Walker, Z. et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology 62, 1568-1572 (2004).
    • (2004) Neurology , vol.62 , pp. 1568-1572
    • Walker, Z.1
  • 146
    • 0030979769 scopus 로고    scopus 로고
    • Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity
    • Vander Borght, T. et al. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J. Nucl. Med. 38, 797-802 (1997).
    • (1997) J. Nucl. Med , vol.38 , pp. 797-802
    • Vander Borght, T.1
  • 147
    • 0034840946 scopus 로고    scopus 로고
    • Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation
    • Minoshima, S. et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann. Neurol. 50, 358-365 (2001).
    • (2001) Ann. Neurol , vol.50 , pp. 358-365
    • Minoshima, S.1
  • 148
    • 0032768776 scopus 로고    scopus 로고
    • Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample
    • Luis, C. A. et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int. J. Geriatr. Psychiatry 14, 526-533 (1999).
    • (1999) Int. J. Geriatr. Psychiatry , vol.14 , pp. 526-533
    • Luis, C.A.1
  • 149
    • 36248979076 scopus 로고    scopus 로고
    • A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies
    • Yong, S. W., Yoon, J. K., An, Y. S. & Lee, P. H. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur. J. Neurol. 14, 1357-1362 (2007).
    • (2007) Eur. J. Neurol , vol.14 , pp. 1357-1362
    • Yong, S.W.1    Yoon, J.K.2    An, Y.S.3    Lee, P.H.4
  • 150
    • 0347385143 scopus 로고    scopus 로고
    • Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study
    • Bohnen, N. I. et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch. Neurol. 60, 1745-1748 (2003).
    • (2003) Arch. Neurol , vol.60 , pp. 1745-1748
    • Bohnen, N.I.1
  • 151
    • 68249119247 scopus 로고    scopus 로고
    • Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET
    • Shimada, H. et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73, 273-278 (2009).
    • (2009) Neurology , vol.73 , pp. 273-278
    • Shimada, H.1
  • 152
    • 79957453213 scopus 로고    scopus 로고
    • Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: Which is more important?
    • Compta, Y. et al. Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain 134, 1493-1505 (2011).
    • (2011) Brain , vol.134 , pp. 1493-1505
    • Compta, Y.1
  • 153
    • 34248579291 scopus 로고    scopus 로고
    • Imaging beta-amyloid burden in aging and dementia
    • Rowe, C. C. et al. Imaging beta-amyloid burden in aging and dementia. Neurology 68, 1718-1725 (2007).
    • (2007) Neurology , vol.68 , pp. 1718-1725
    • Rowe, C.C.1
  • 154
    • 56749185181 scopus 로고    scopus 로고
    • Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
    • Edison, P. et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J. Neurol. Neurosurg. Psychiatry 79, 1331-1338 (2008).
    • (2008) J. Neurol. Neurosurg. Psychiatry , vol.79 , pp. 1331-1338
    • Edison, P.1
  • 155
    • 54049100454 scopus 로고    scopus 로고
    • Imaging amyloid deposition in Lewy body diseases
    • Gomperts, S. N. Imaging amyloid deposition in Lewy body diseases. Neurology 71, 903-910 (2008).
    • (2008) Neurology , vol.71 , pp. 903-910
    • Gomperts, S.N.1
  • 156
    • 84867510729 scopus 로고    scopus 로고
    • Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia
    • Petrou, M. et al. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology 79, 1161-1167 (2012).
    • (2012) Neurology , vol.79 , pp. 1161-1167
    • Petrou, M.1
  • 157
    • 37849039499 scopus 로고    scopus 로고
    • [11C] PIB binding in Parkinson's disease dementia
    • Maetzler, W. et al. [11C]PIB binding in Parkinson's disease dementia. Neuroimage 39, 1027-1033 (2008).
    • (2008) Neuroimage , vol.39 , pp. 1027-1033
    • Maetzler, W.1
  • 158
    • 84873647470 scopus 로고    scopus 로고
    • Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
    • Gomperts, S. N. et al. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology 80, 85-91 (2013).
    • (2013) Neurology , vol.80 , pp. 85-91
    • Gomperts, S.N.1
  • 159
    • 0034684139 scopus 로고    scopus 로고
    • Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial
    • Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. JAMA 284, 1931-1938 (2000).
    • (2000) JAMA , vol.284 , pp. 1931-1938
  • 160
    • 19744378296 scopus 로고    scopus 로고
    • Levodopa and the progression of Parkinson's disease
    • The Parkinson Study Group. Levodopa and the progression of Parkinson's disease. N. Engl. J. Med. 351, 2498-2508 (2004).
    • (2004) N. Engl. J. Med , vol.351 , pp. 2498-2508
  • 161
    • 0037785449 scopus 로고    scopus 로고
    • Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
    • Whone, A. L. et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann. Neurol. 54, 93-101 (2003).
    • (2003) Ann. Neurol , vol.54 , pp. 93-101
    • Whone, A.L.1
  • 162
    • 0038249170 scopus 로고    scopus 로고
    • Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
    • Gill, S. S. et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589-595 (2003).
    • (2003) Nat. Med , vol.9 , pp. 589-595
    • Gill, S.S.1
  • 163
    • 0030834093 scopus 로고    scopus 로고
    • Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
    • Wenning, G. K. et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42, 95-107 (1997).
    • (1997) Ann. Neurol , vol.42 , pp. 95-107
    • Wenning, G.K.1
  • 164
    • 0033934144 scopus 로고    scopus 로고
    • Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
    • Brundin, P. et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123, 1380-1390 (2000).
    • (2000) Brain , vol.123 , pp. 1380-1390
    • Brundin, P.1
  • 165
    • 0028990705 scopus 로고
    • Transplantation of fetal mesencephalic tissue in Parkinson's disease
    • Freed, C. R., Breeze, R. E. & Schneck, S. A. Transplantation of fetal mesencephalic tissue in Parkinson's disease. N. Engl. J. Med. 333, 730-731 (1995).
    • (1995) N. Engl. J. Med , vol.333 , pp. 730-731
    • Freed, C.R.1    Breeze, R.E.2    Schneck, S.A.3
  • 166
    • 0042837887 scopus 로고    scopus 로고
    • A Double blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
    • Olanow, C. W. et al. A Double blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54, 403-414 (2003).
    • (2003) Ann. Neurol , vol.54 , pp. 403-414
    • Olanow, C.W.1
  • 167
    • 84870260355 scopus 로고    scopus 로고
    • In vivo imaging of the integration and function of nigral grafts in clinical trials
    • Politis, M. & Piccini, P. In vivo imaging of the integration and function of nigral grafts in clinical trials. Prog. Brain Res. 200, 199-220 (2012).
    • (2012) Prog. Brain Res , vol.200 , pp. 199-220
    • Politis, M.1    Piccini, P.2
  • 168
    • 0036307190 scopus 로고    scopus 로고
    • Dyskinesias following neural transplantation in Parkinson's disease
    • Hagell, P. et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat. Neurosci. 5, 627-628 (2002).
    • (2002) Nat. Neurosci , vol.5 , pp. 627-628
    • Hagell, P.1
  • 169
    • 0036830588 scopus 로고    scopus 로고
    • Dyskinesia after fetal cell transplantation for parkinsonism: A PET study
    • Ma, Y. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann. Neurol. 52, 628-634 (2002).
    • (2002) Ann. Neurol , vol.52 , pp. 628-634
    • Ma, Y.1
  • 170
    • 77955617871 scopus 로고    scopus 로고
    • Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants
    • Politis, M. et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2, 38ra46 (2010).
    • (2010) Sci. Transl. Med , vol.2
    • Politis, M.1
  • 171
    • 78649534741 scopus 로고    scopus 로고
    • Dyskinesias after neural transplantation in Parkinson's disease: What do we know and what is next?
    • Politis, M. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next? BMC Med. 8, 80 (2010).
    • (2010) BMC Med , vol.8 , pp. 80
    • Politis, M.1
  • 172
    • 80052971467 scopus 로고    scopus 로고
    • Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio
    • Politis, M. et al. Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio. Mov. Disord. 26, 1997-2003 (2011).
    • (2011) Mov. Disord , vol.26 , pp. 1997-2003
    • Politis, M.1
  • 173
    • 84892394291 scopus 로고    scopus 로고
    • Long-term clinical outcome of fetal cell transplantation for Parkinson disease: Two case reports
    • Kefalopoulou, Z. et al. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports. JAMA Neurol. 71, 83-87 (2014).
    • (2014) JAMA Neurol , vol.71 , pp. 83-87
    • Kefalopoulou, Z.1
  • 174
    • 84855291126 scopus 로고    scopus 로고
    • Clinical application of stem cell therapy in Parkinson's disease
    • Politis, M. & Lindvall, O. Clinical application of stem cell therapy in Parkinson's disease. BMC Med. 10, 1 (2012).
    • (2012) BMC Med , vol.10 , pp. 1
    • Politis, M.1    Lindvall, O.2
  • 175
    • 79955718250 scopus 로고    scopus 로고
    • Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease
    • Politis, M. Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease. BMC Med. 9, 50 (2011).
    • (2011) BMC Med , vol.9 , pp. 50
    • Politis, M.1
  • 177
    • 51549120220 scopus 로고    scopus 로고
    • Simultaneous MR/PET imaging of the human brain: Feasibility study
    • Schlemmer, H. P. et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248, 1028-1035 (2008).
    • (2008) Radiology , vol.248 , pp. 1028-1035
    • Schlemmer, H.P.1
  • 178
    • 84884139383 scopus 로고    scopus 로고
    • Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone
    • Andersen, F. L. et al. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone. Neuroimage 84, 206-216 (2014).
    • (2014) Neuroimage , vol.84 , pp. 206-216
    • Andersen, F.L.1
  • 181
    • 84874107768 scopus 로고    scopus 로고
    • MRI for attenuation correction in PET: Methods and challenges
    • Wagenknecht, G., Kaiser, H. J., Mottaghy, F. M. & Herzog, H. MRI for attenuation correction in PET: methods and challenges. MAGMA 26, 99-113 (2013).
    • (2013) MAGMA , vol.26 , pp. 99-113
    • Wagenknecht, G.1    Kaiser, H.J.2    Mottaghy, F.M.3    Herzog, H.4
  • 182
    • 84884273839 scopus 로고    scopus 로고
    • Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls
    • Maruyama, M. et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79, 1094-1108 (2012).
    • (2012) Neuron , vol.79 , pp. 1094-1108
    • Maruyama, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.